Latest Healthcare It News

Page 8 of 142
Iperion reported a lower loss for the year ended 31 March 2026, but its cash reserves and net assets fell sharply, leaving the NZX-listed materials company reliant on related-party funding and director support. Its Pathoglaze manufacturing operation is also being moved from Malaysia to Singapore while customer trials continue.
Victor Sage
Victor Sage
30 Sept 2026
Alcidion will roll out its Miya Flow software across four Northern Care Alliance hospitals under a new A$7.5 million contract. About A$4.5 million is expected to be recognised as revenue in the current year, including a six-month renewal of the existing ExtraMed system during implementation.
Victor Sage
Victor Sage
30 Sept 2026
RAM Essential Services Property Fund has posted a $30.1 million FY2026 statutory loss as property values weakened, while its planned $218.6 million retail sale prepares the fund for a healthcare-focused reset. The transaction could reduce gearing to 16.8%, but FY2027 distribution guidance is below the latest payout and refinancing remains unfinished.
Eva Park
Eva Park
29 Sept 2026
Stakk has secured a live signature verification engagement for use by the United States Federal Bureau of Investigation through ParaScript, with the agreement running to December 2027. The company says the contract will contribute meaningfully to its FY2027 revenue target, now expected to exceed $55 million, although its value remains confidential.
Sophie Babbage
Sophie Babbage
29 Sept 2026
Embelton Limited (ASX:EMB) grew revenue, profit and operating cash flow in FY2026 despite subdued residential construction, while maintaining its 35-cent fully franked annual dividend. The flooring and engineering group is leaning further into infrastructure, data centres, healthcare and other commercial work, although its near-term contracting pipeline remains modest.
Victor Sage
Victor Sage
28 Sept 2026
Enlitic has secured a US$806,000 contract to migrate 10.6 million medical imaging studies for University of Michigan Health-Sparrow. The project also gives its Ensight platform a first active integration with Sectra’s enterprise imaging environment.
Victor Sage
Victor Sage
28 Sept 2026
Marlin Global’s portfolio fell 6.3% before fees and tax in FY26 while its benchmark gained 30.5%, producing a NZ$17.3 million net loss. The Fisher Funds-managed vehicle is responding with broader sector coverage, faster portfolio turnover and an expanded research team.
Victor Sage
Victor Sage
28 Sept 2026
Barramundi Limited (NZX:BRM) has reported the worst performance in its 20-year history, with a NZ$42.9 million net loss and a 17.0% fall in gross portfolio performance. The board is reviewing Fisher Funds’ management performance just weeks before its five-year agreement comes up for renewal.
Claire Turing
Claire Turing
28 Sept 2026
Betashares’ newly launched FTSE Global Infrastructure Shares Currency Hedged ETF reported $1.204 billion in profit and $8.08 billion in net assets for its first reporting year. The audited results also show strong gains across several established funds, alongside sharp post-year-end NAV movements in energy and gold miners.
Claire Turing
Claire Turing
25 Sept 2026
HealthCo Healthcare and Wellness REIT (ASX: HCW) reported a $49.7 million FY26 statutory loss, suspended distributions and received an unmodified audit opinion that nevertheless highlighted a material uncertainty over its ability to continue as a going concern. The key unresolved issue is the transfer of 10 Healthscope hospitals to alternative operators.
Eva Park
Eva Park
25 Sept 2026
GWA Group delivered its third consecutive year of volume growth in FY26, lifting revenue, normalised EBIT and its fully franked dividend despite weak housing and renovation conditions. The trade-off was a sharp decline in operating cash flow and higher net debt following inventory purchases and a $25 million share buyback.
Victor Sage
Victor Sage
25 Sept 2026
Sonic Healthcare delivered a strong FY2026, with underlying net profit up 17% to A$621 million and dividends rising to A$1.08 per share. The next test is whether US efficiencies, LADR synergies and organic growth can offset Swiss fee cuts, a delayed UK contract ramp-up and heavier investment demands.
Ada Torres
Ada Torres
24 Sept 2026

Browse the archive

Full archive